Iverjohn 12mg (Ivermectin Tablet) 12 mg

Iverjohn 12mg is an antiparasitic medication used to treat a range of parasitic infections. It is effective against the following conditions:

• Onchocerciasis: Reduces the number of microfilariae in the skin and helps prevent blindness caused by the Onchocerca volvulus parasite.
• Strongyloidiasis: Treats intestinal infections caused by the Strongyloides stercoralis parasite, reducing symptoms and preventing complications.
• Lymphatic filariasis: Helps to eliminate the parasitic worms that cause this condition, reducing symptoms and preventing long-term damage.
• Scabies: Effective against the Sarcoptes scabiei mite, reducing itching and skin rashes.
• Pediculosis: Treats head lice infestations by killing the parasites and preventing their reproduction.

• Ivermectin binds selectively to glutamate-gated chloride channels in parasite nerve and muscle cells. This increases the permeability of the parasite's cell membrane to chloride ions, leading to hyperpolarization of the cell membrane. The resulting paralysis and disruption of normal bodily functions cause the parasite to die and be cleared by the body's immune system.

Iverjohn 12mg may cause side effects, although not everyone experiences them. Common Side Effects:

• Headache and dizziness
• Nausea or mild stomach discomfort
• Fatigue
• Skin itching or mild rash
• Joint or muscle pain

Serious or Rare Side Effects

• Severe allergic reactions, including swelling of the face, lips, or throat
• Neurological symptoms, such as seizures or confusion
• Severe skin reactions, including blistering or peeling
• Liver problems, indicated by yellowing of the skin or eyes
• Kidney problems, indicated by changes in urine output or color

Iverjohn 12mg should be used with caution and under medical supervision. Consult your doctor before use if you have any of the following conditions:

• Allergy: Do not use if you are allergic to ivermectin or any ingredient in the tablet.
• Pregnancy: Limited safety data available; consult your doctor before use.
• Breastfeeding: Ivermectin passes into breast milk; discuss with your healthcare provider.
• Severe liver disease: Ivermectin is metabolised in the liver; dose adjustment may be required.
• Loa loa co-infection: Patients from West or Central Africa being treated for onchocerciasis should be screened for loiasis before treatment, as serious neurological reactions have been reported.
• Store below 25°C: Keep in the original pack, protect from moisture.

Iverjohn 12mg may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major Interactions (Avoid):

• Blood thinners: May increase the risk of bleeding.
• Corticosteroids: May increase the risk of immune system suppression.
• Certain antibiotics: May alter the effectiveness of ivermectin.

Moderate Interactions (Monitor Closely)

• Alcohol: May increase the risk of side effects such as dizziness or drowsiness.
• Grapefruit juice: May affect how ivermectin is metabolized, potentially increasing blood levels.
• Other antiparasitic medications: May increase the risk of side effects or reduce effectiveness.